Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122716415 | 12271641 | 5 | F | 20150822 | 20160720 | 20160415 | 20160726 | EXP | FR-BEH-2016061153 | CSL BEHRING | 63.00 | YR | A | F | Y | 50.00000 | KG | 20160726 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122716415 | 12271641 | 1 | PS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | 4326200037 | 125201 | INFUSION | |||||||||
| 122716415 | 12271641 | 2 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | UNK | 4326200048 | 125201 | INFUSION | ||||||||
| 122716415 | 12271641 | 3 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | 400 MG/KG, QD | 4326200048 | 125201 | 400 | MG/KG | INFUSION | QD | |||||
| 122716415 | 12271641 | 4 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | 400 MG/KG, QD | 4326200038 | 125201 | 400 | MG/KG | INFUSION | QD | |||||
| 122716415 | 12271641 | 5 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 122716415 | 12271641 | 6 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 122716415 | 12271641 | 7 | SS | VP 16 | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 122716415 | 12271641 | 8 | SS | VP 16 | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 122716415 | 12271641 | 9 | C | Lercanidipine | LERCANIDIPINE | 1 | Oral | START DATE: ??-NOV-2008 | 0 | 100 | MG | QD | |||||||
| 122716415 | 12271641 | 10 | C | PREGABALIN. | PREGABALIN | 1 | Oral | START DATE: ??-JUN-2015 | 0 | 300 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122716415 | 12271641 | 1 | Paraneoplastic neurological syndrome |
| 122716415 | 12271641 | 2 | Anti-neuronal antibody positive |
| 122716415 | 12271641 | 5 | Lung neoplasm malignant |
| 122716415 | 12271641 | 7 | Lung neoplasm malignant |
| 122716415 | 12271641 | 9 | Hypertension |
| 122716415 | 12271641 | 10 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122716415 | 12271641 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122716415 | 12271641 | Acute kidney injury | |
| 122716415 | 12271641 | Chills | |
| 122716415 | 12271641 | Hypoxia | |
| 122716415 | 12271641 | Labile blood pressure | |
| 122716415 | 12271641 | Pancytopenia | |
| 122716415 | 12271641 | Pseudomonal sepsis | |
| 122716415 | 12271641 | Pyrexia | |
| 122716415 | 12271641 | Sinus tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122716415 | 12271641 | 1 | 20150710 | 20150711 | 0 | |
| 122716415 | 12271641 | 2 | 20150712 | 20150714 | 0 | |
| 122716415 | 12271641 | 3 | 20150810 | 20150811 | 0 | |
| 122716415 | 12271641 | 4 | 20150812 | 20150814 | 0 | |
| 122716415 | 12271641 | 5 | 20150722 | 20150724 | 0 | |
| 122716415 | 12271641 | 6 | 20150817 | 0 | ||
| 122716415 | 12271641 | 7 | 20150722 | 20150724 | 0 | |
| 122716415 | 12271641 | 8 | 20150817 | 0 |